SOLIX BIOSYSTEMS, INC. – Trademark Portfolio
Entity Type: 03
SOLIX BIOSYSTEMS, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 8 Nice Classification classes. The owner is based in FORT COLLINS, CO.
430 B. NORTH COLLEGE AVE.
FORT COLLINS, CO 80524
Showing of trademarks Trademarks
Trademark Classifications
SOLIX BIOSYSTEMS, INC.'s trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does SOLIX BIOSYSTEMS, INC. have?
SOLIX BIOSYSTEMS, INC. has 10 U.S. trademarks filed with the USPTO.
What trademark classes does SOLIX BIOSYSTEMS, INC. file in?
SOLIX BIOSYSTEMS, INC. files trademarks across 8 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 29 (Meats & Processed Foods), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What is SOLIX BIOSYSTEMS, INC.'s trademark registration success rate?
SOLIX BIOSYSTEMS, INC. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.